Market Overview

15 Biggest Mid-Day Gainers For Monday

Share:
  • Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC) shares surged 51 percent to $5.17. Cyclacel announced the presentation demonstrating therapeutic potential of CYC065 in lung cancer at the AACR 2017.
  • Novocure Ltd (NASDAQ: NVCR) shares climbed 46 percent to $11.82 after the company disclosed that the two-year survival rate for GBM Patients increased from 30% to 43% for patients treated with Optune + temozolomide versus temozolomide alone at the AACR 2017.
  • Steadymed Ltd (NASDAQ: STDY) shares surged 38.4 percent to $8.10. Cardiome's partner SteadyMed received a favorable ruling in USPTO Inter Partes Review in validity of U.S. Patent No. 8,497,393.
  • Polarityte Inc (NASDAQ: COOL) shares rose 31 percent to $17.90.
  • China Auto Logistics Inc (NASDAQ: CALI) shares surged 17 percent to $1.77.
  • GEE Group Inc (NYSE: JOB) gained 15.5 percent to $5.65. GEE Group has acquired SNI Companies through merger.
  • Professional Diversity Network Inc (NASDAQ: IPDN) climbed 12.1 percent to $10.75. Professional Diversity Network reported a FY16 loss of $1.98 per share on revenue of $26.23 million.
  • AirMedia Group Inc (ADR) (NASDAQ: AMCN) shares jumped 10.6 percent to $3.04.
  • Matinas BioPharma Holdings Inc (NYSE: MTNB) rose 8.3 percent to $3.00 in pre-market trading. Matinas BioPharma reported a FY16 loss of $0.21 per share.
  • Cellect Biotechnology Ltd. (NASDAQ: APOP) rose 7.2 percent to $9.22 after the company reported an European patent grant.
  • Eleven Biotherapeutics Inc (NASDAQ: EBIO) rose 6.8 percent to $2.35. Eleven Biotherapeutics presented new preclinical data supporting potential of the company's locally and systematically-administered drug candidates at the AACR 2017.
  • Kite Pharma Inc (NASDAQ: KITE) climbed 5.6 percent to $82.86. Kite presented ongoing response rate in plenary session from its pivotal CAR-T trial of Axicabtagene Ciloleucel in patients with aggressive non-hodgkin lymphoma at AACR 2017.
  • Syneron Medical Ltd. (NASDAQ: ELOS) shares gained 5.3 percent to $11.11. Syneron Candela agreed to be acquired by funds advised by Apax Partners for $11 per share in cash.
  • Infinity Pharmaceuticals Inc. (NASDAQ: INFI) rose 5 percent to $3.39. Infinity Pharmaceuticals presented updated Phase 1 data for IPI-549 at the AACR 2017.
  • Loxo Oncology Inc (NASDAQ: LOXO) gained 4.7 percent to $44.05. Morgan Stanley initiated coverage on Loxo Oncology with an Overweight rating.

Posted-In: Mid-Day GainersNews Intraday Update Markets Movers

 

Related Articles (AMCN + APOP)

View Comments and Join the Discussion!

Elon Musk Loves To Call Out Short Sellers

Lumber Liquidators Higher For Fifth Day In A Row